The delay in the diagnosis of neonatal stroke makes the application of therapies that would induce reperfusion unrealistic, including endovascular therapy (physical clot removal) and clot-dissolving therapy (i.e., the administration of tissue-type plasminogen activator, tPA), which need to be applied within 3–4 h of stroke onset. Here, PLAT is linked to Stroke.